INTRODUCTION
Innate immune responses that trigger type-I interferon (IFN) secretion have been implicated in HIV-1 transmission and pathogenesis (Gringhuis et al., 2010; Iwasaki, 2012; Meier et al., 2009) . HIV-1 has evolved countermeasures to escape the activities of several IFN-stimulated genes (ISGs), and those mechanisms not disabled by the virus define both cell type and species tropisms (Kirchhoff, 2010) . Recent data suggest that one or more intrinsic signaling pathways sense invariant features encoded by HIV-1 and initiate innate immune responses, including IFN secretion Jakobsen et al., 2013; Manel et al., 2010; Rasaiyaah et al., 2013) . This response is proximally mediated by recognition of specific viral components in infected cells by pattern recognition receptors (PRRs), resulting in the activation of transcription factors that participate in ISG expression and IFN synthesis, such as IRF3 (Luban, 2012; Paludan and Bowie, 2013) . Dendritic cells (DCs) play a critical role in immune response to viral infection through the facilitation of cell-intrinsic antiviral activity and the activation of adaptive immunity. Human DCs are resistant to HIV-1 infection because of expression of SAMHD1, a phosphohydrolase that functions to deplete cellular nucleotide pools (Berger et al., 2011; Goldstone et al., 2011; Lahouassa et al., 2012) . SAMHD1 restriction can be overcome in DCs by the introduction of HIV-2-or SIV-encoded Vpx, both of which target SAMHD1 for ubiquitin-mediated degradation (Hrecka et al., 2011; Laguette et al., 2011 Laguette et al., , 2012 . Manel et al. (2010) have demonstrated that co-transduction of DCs with HIV-1 and SIV VLP-Vpx not only enables productive infection but also results in the activation of DCs and IRF3-dependent production of IFN.
Furthermore, studies have shown that this IRF3-dependent innate immune response requires the activity of cyclic GAMP synthase (cGAS) Sun et al., 2013; Wu et al., 2013) . cGAS has been identified as a critical mediator of the innate response to cytosolic DNA through synthesis of a cyclic guanosine monophosphate-adenosine monophosphate isomer (cGAMP) . While cGAS was shown to regulate anti-viral responses to HIV-1 and other retroviruses, its direct association with a retroviral-encoded PAMP has not been demonstrated Li et al., 2013) . Additionally, the apparent low affinity of cGAS for DNA and the promiscuous response to a broad set of DNA ligands suggests that co-receptors may function to enhance affinity for non-self DNA during cGAS-dependent innate signaling (Kranzusch and Vance, 2013) . Results from this study indicate that the polyglutamine binding protein 1 (PQBP1) protein functions as a specific co-receptor for reverse-transcribed HIV-1 DNA and complexes with cGAS to initiate an immune response to retroviral infection.
RESULTS
As previously observed, when monocyte-derived DCs (MDDCs) were co-infected with SIV VLP-Vpx and vesicular stomatitis virus G protein (VSV-G)-HIV-1 (hereafter HIV/Vpx), we detected robust expression of IRF3-dependent target genes ISG54 and IP-10, peaking at 16 hr post-infection ( Figure 1A ; Figure S1A ). Infection with either HIV-1 or Vpx alone did not result in an appreciable increase of these transcripts ( Figure 1A ). Expression of ISG54 in response to HIV/Vpx was accompanied by phosphorylationdependent activation of IRF3 and its upstream regulator, IKKε ( Figure 1B ). In addition, ISG54 induction by HIV/Vpx was IRF3 dependent, as demonstrated by IRF3 silencing; depletion of IRF3, but not p65, attenuated early induction of ISG54 (Figures 1C and S1B) . Consistent with a previous report , we found that this signaling response required reverse transcription (RT) of HIV-1 RNA, but not viral DNA integration treatment with Nevirapine (NVP), an RT inhibitor, reduced ISG54 expression and phosphorylation of IRF3, but treatment with the integrase inhibitor Raltegravir (Ral) did not (Figures 1A and 1B) . Both treatments were effective as they potently inhibited viral replication, but they did not affect cell viability or innate responses to non-HIV-1 stimuli (Figure 1A, right; Figure S1C) . These data confirm that HIV-1 elicits an IRF3-dependent innate immune response in MDDCs through a process that requires viral reverse transcription.
To identify potential co-sensors that regulate this response, we performed a targeted RNAi screen in primary MDDCs. Because our data suggest that a viral DNA-containing species is likely responsible for the initiation of signaling, we reasoned The scramble control activities are depicted in the large red circles. The horizontal dotted line reflects the three SD cutoff from the controls. The p value was determined by one-tailed, unpaired t test (p % 0.0001). This screen was run in biological duplicates. Except in (D), all data are shown as the average ± SD of biological triplicates. *p < 0.05 as determined by one-way ANOVA with Tukey's post-test. (A)-(C) represent data from at least three independent experiments. See also Figure S1 and Table S1 for additional validation studies of the screening platform.
that putative receptors would possess annotated nucleic acid binding activity and be preferentially expressed in myeloid cells.
Based on these criteria, we assembled a sub-genomic RNAi library of 351 putative sensors (see Experimental Procedures; Table S1 ). Each candidate gene was individually depleted by transfecting a pool of four small interfering RNAs (siRNAs) per gene into MDDCs. After 48 hr, the cells were challenged with HIV/Vpx, and induction of innate signaling was measured by monitoring ISG54 expression ( Figure 1D ; Table S1 ). We identified 26 genes that when depleted inhibited ISG54 mRNA induction greater than three SD below the scrambled controls ( Figure 1D ; Table S1 , p % 0.0001).
To further validate these results, four siRNAs for each putative sensor were tested independently. One of the strongest candidates that reproducibly and potently inhibited ISG54 induction with at least two sequence-independent siRNAs targeted the gene PQBP1 (Figure 2A ; Figures S2A-S2C; Table S1 ). PQBP1 is a polyglutamine-binding protein, and mutations in the Figure 3. PQBP1 Associates with Immunogenic HIV-1 DNA (A) MDDCs were challenged with HIV/Vpx for 3 or 16 hr, followed by formaldehyde cross-linking. The abundance of HIV-1-encoded nucleic acids associating with the PQBP1 IP or the ZC3H3 IP was evaluated using qRT-PCR using primers for the HIV-1 strong stop sequence (left) (eRT primers; Table S2 ). The values are relative to the level of nucleic acids that precipitated by normal IgG from the 3-hr-infected lysate. Binding specificity of the antibodies was confirmed by western blot of the immunoprecipitants (right). The schematic depicts the HIV-1 genome with the three sets of primers used to measure the amount of HIV-1 nucleic acid. See also Figure S3C . (legend continued on next page) PQBP1 locus are associated with neurodegenerative pathologies, including Renpenning and other syndromes associated with X-linked mental disorders (XLMR; Germanaud et al., 2011; Kalscheuer et al., 2003; Lenski et al., 2004; Marubuchi et al., 2005) . RNAi depletion of a putative nucleic acid sensor LRRFIP1, a gene that did not meet the three SD threshold in the original screen, did not reduce ISG54 induction when compared to the scrambled controls (Figure 2A ), and it was thus used as a negative control in subsequent experiments. The PQBP1-dependent induction of innate immune signaling after HIV-1 infection was not unique to MDDCs. Knockdown of PQBP1 in the monocyte-like cell line THP-1 also resulted in reduced ISG54 induction after HIV-1 infection ( Figure S2D ). We investigated the possibility that PQBP1 was reducing ISG induction through interference with HIV-1 replication. However, HIV-1 infection was unimpeded in the absence of PQBP1, as compared to cells harboring a control small hairpin RNA (shRNA) ( Figure S2E ). Evaluation of IKKε and IRF3 phosphorylation after HIV/Vpx challenge in PMA-differentiated THP-1 cells (hereafter THP-1) depleted of PQBP1 indicated that PQBP1 acts as a positive regulator of ISG54 and IP-10 induction upstream of IKKε/ IRF3 phosphorylation ( Figure 2B ; Figure S2C ). To exclude potential off-target siRNA effects, THP-1 lines that stably expressed either wild-type PQBP1 or siRNA-resistant PQBP1 cDNAs were generated, transfected with a siRNA targeting PQBP1, and challenged with HIV/Vpx. Expression of the siRNA-resistant PQBP1 (siR) restored ISG54 and IP10 expression in response to infection (Figures 2C and S2F) . However, those cells harboring wild-type PQBP1 displayed attenuated induction of ISG54 ( Figures 2C and S2F ). Additionally, we employed a CRISPRmediated genome editing approach to target PQBP1 (cPQBP1; Supplemental Experimental Procedures). We were unable to generate lines harboring genetically null mutations for PQBP1, but we were successful in recovering several hypomorphic mutations in the PQBP1 locus that resulted in significantly diminished levels of PQBP1 expression. Similar to transient silencing of PQBP1 in DCs or THP-1 cells, we found genome editing of PQBP1 in THP-1 cells abrogated ISG54 induction after HIV/ Vpx infection, but not after HT-DNA stimulation ( Figure 2D ). ISG54 induction was rescued after adding a stable, ectopically expressed PQBP1 ( Figure 2E ).
We subsequently sought to determine if PQBP1 directly associated with HIV-1-encoded PAMPs. To this end, MDDCs were infected with HIV/Vpx for 3 or 16 hr, formaldehyde cross-linked, lysed, and subjected to immunoprecipitations (IP) of endogenous PQBP1 or ZC3H3, another nucleic acid binding protein that was identified in our screen (Table S1 ). Specific pull down of PQBP1 or ZC3H3 proteins was confirmed by western blot ( Figure 3A , right), and HIV-1-derived nucleic acids associating with the normal serum, ZC3H3, and PQBP1 IPs were quantitated by qRT-PCR. We found that a significant and specific enrichment of HIV-1-derived nucleic acids was associated with the PQBP1 IP, but not with the ZC3H3 or control IP (normal immunoglobulin G [IgG]) ( Figure 3A ; Figures S3A and S3B ). To further confirm the selectivity of binding, a recombinant glutathione S-transferase (GST)-tagged PQBP1 protein was added during the IP to displace endogenous PQBP1. Addition of exogenous PQBP1 reduced the level of HIV-1 nucleic acids in the immunoprecipitants (S3C). To understand whether PQBP1 association with HIV-1 DNA required the innate regulator cGAS, cells that stably expressed an shRNA vector targeting either luciferase or cGAS were infected for 6 hr. They were then cross-linked, and PQBP1 was immunoprecipitated from the lysate, as described above. Despite the absence of cGAS, PQBP1 was still able to associate with HIV-1 nucleic acids ( Figure 3B ). Next, to identify the species of HIV-1-encoded nucleic acid that was involved in this activity, the IPs were treated with either DNase or RNase A/H prior to qRT-PCR or qPCR analysis, respectively ( Figure 3C ). HIV-1 nucleic acid products were detected only in the samples treated with RNase A/H ( Figure 3C ). Additionally, PQBP1 binding to the HIV-1 nucleic acids was significantly reduced in the presence of the RT inhibitor NVP but was not affected by the integrase inhibitor Ral ( Figure 3D ). These data suggest that an HIV-1 DNA intermediate product associates with PQBP1.
To characterize the activity of HIV-1 DNA in the cytosol of infected cells, MDDCs were infected with HIV/Vpx for 6 hr and then fractionated into soluble non-chromatin (SNC) and chromatin (C) fractions ( Figure S3F ). At this time point after infection, we found that HIV-1-encoded nucleic acids exist primarily in the SNC ( Figure S3F ). Consistently, electroporation of RNase-A/H-resistant nucleic acids isolated from either the SNC or C fractions of HIV-1-infected MDDCs into naive THP-1 cells harboring a stable shRNA toward PQBP1 ( Figure 3E ) revealed that DNA, or possibly an RNaseH-resistant RNA-DNA hybrid species, present in the soluble fraction of infected cells is immunogenic, and the immune response to this ligand is dependent upon PQBP1 expression in uninfected target cells ( Figure 3F ).
We then tested whether the PQBP1-associated HIV-1 DNA product was itself immunogenic. DNA immunoprecipitated from the infected MDDC lysate by the PQBP1 antibody or the control normal IgG was electroporated into THP-1 in the presence or absence of PQBP1. We found that only PQBP1-associated nucleic acids led to the enhancement of ISG54 expression and that this innate response was sharply attenuated in the (E) Knockdown efficiency of PQBP1 in THP-1 cells expressing shRNAs against a scramble control or the PQBP1 protein was measured by qRT-PCR (left) and western blot (right). (F) Infected MDDC lysates were separated into soluble non-chromatin (SNC) and chromatin (C) fractions. DNA isolated from each fraction, and a plasmid encoding HIV-1 proviral DNA (circular or linearized), were electroporated into THP-1 cells harboring a shRNA control or shRNA-targeting PQBP1, and ISG54 expression was measured. absence of PQBP1 in the target cells ( Figure 3G ). This innate induction was specific to a reverse-transcribed DNA product, since the PQBP1-IP product from cells treated with NVP during infection failed to induce ISG54 expression in target cells (Figure 3H) . Taken together, these results suggest that PQBP1 directly associates with immunogenic HIV-1 DNA.
Next, we evaluated the breadth of nucleic acid stimuli that are governed by a PQBP1-dependent innate response. In contrast to HIV-1, the innate immune response to an RNA virus, Sendai virus, was not dependent upon PQBP1 in THP-1 (S4A). Further, the dependence on PQBP1 for HIV-1 DNA recognition did not extend to all cytoplasmic DNA, as response to B-DNA (poly(dA:dT)) and Herring testis (HT)-DNA was not reliant on PQBP1 in MDDCs or THP-1 cells (Figures 4A and 4B ; Figures  S4B and S4C) . Consistent with these results, PQBP1 depletion did not dampen the immune response to the double-stranded DNA virus MHV-68 ( Figure 4C ), and MHV-68 DNA did not associate with PQBP1 after infection, despite a greater abundance of MHV-68 in the lysate (Figures 4D and S4D) . Feline immunodeficiency virus (FIV) and equine infectious anemia virus (EIAV) are both retroviruses that are divergent from HIV-1 but maintain the requirement of a reverse-transcription step for viral propagation. Both VSV-G-pseudotyped retroviruses induced an innate response in THP-1. However, in the absence of the PQBP1 protein, the response was sharply reduced (Figures 4E and 4F ; Figure S4E ). Taken together, these data indicate that PQBP1 specifically recognizes a retroviral DNA product.
Similar to previous reports , we found that depletion of cGAS in MDDCs resulted in decreased ISG54 induction by both HT-DNA and HIV-1 ( Figure 5A ; Figure S5A ). Since PQBP1 is dispensable for the innate response to HT-DNA and MHV-68 ( Figures 4A-4C) , both of which have been reported to be sensed by cGAS (Schoggins et al., 2014; Sun et al., 2013) , our data suggest that PQBP1 regulates the response to a more restricted set of cGAS-dependent DNA ligands. However, because both PQBP1 and cGAS were required for response to a RT DNA PAMP produced by HIV-1 infection , we sought to determine whether PQBP1 and cGAS modulate the response to HIV-1 through coincident or parallel pathways. We evaluated whether PQBP1-depleted cells could (Table S2) . (E) PMA-differentiated shControl or shPQBP1 THP-1 cells were infected with VSV-G pseudotyped FIV or EIAV, followed by measuring ISG54 induction. (F) CRISPR PQBP1 clones were infected with increasing MOIs of FIV (left) or MHV-68 (right), and ISG54 induction was measured. All data except (D) are shown as the average ± SD of biological triplicates and are representative of at least three independent experiments. For the THP-1 infected with MHV-68 in (D), the lysates were pooled from six biological replicates. Significance (*p < 0.05) was determined by one-way ANOVA with Tukey's posttest (A and B) or by an unpaired Student's t test (E). See also Figure S4. respond to exogenously added synthetic cGAMP. When cGAMP molecules were incubated with perfringolysin O (PFO)-treated THP-1 cells harboring PQBP1 shRNA, as previously described , we did not observe a reduction of cGAMPinduced p-IRF3 in comparison to control cells ( Figure 5B ), but there was a reduction of cGAMP-mediated activation in the absence of STING ( Figure 5C ). This result suggested that PQBP1 activity is not required for cGAMP-mediated activation of IRF3. Next, we evaluated the impact of PQBP1 depletion on the synthesis of cGAMP after HIV-1 challenge. Both qRT-PCR analysis and western blot analysis confirmed that depletion of PQBP1 does not reduce cGAS expression ( Figure S5B ). MDDCs or THP-1 were transfected with siPQBP1 and infected with HIV/ Vpx. cGAMP levels in the infected cell lysates were indirectly measured through incubation of PFO-treated THP-1 cells with those lysates, and phosphorylation of IRF3 was assessed ( Figure 5D ). cGAMP levels were also directly quantified by liquid chromatography-tandem mass spectrometry (LC-MS/MS) For the experiments using THP-1, two independent experiments were performed. Significance (*p < 0.05) was determined by an unpaired Student's t test. See also Figure S5 .
(Figures 5E and 5F; Figures S5C-S5E ). In both MDDCs and THP-1, the loss of PQBP1, even in the presence of functional cGAS, resulted in a significant reduction of cGAMP production upon HIV/Vpx infection ( Figures 5D and 5E ). As cGAS is the only enzyme known to generate cGAMP in mammalian cells, we conclude that PQBP1 is required for activation of cGAS during HIV-1 infection of myeloid cells. Consistent with other studies (Waragai et al., 1999; Kunde et al., 2011) , immunofluorescent staining of endogenous PQBP1 revealed that it was localized to both the cytosol and nucleus of MDDCs ( Figure S3E ). To determine if PQBP1, cGAS, and STING are in similar cellular compartments during HIV-1 infection, we performed a subcellular fractionation and found that PQBP1 co-fractionates with cGAS and STING (Figure 6A) . To determine if PQBP1 physically interacts with cGAS, we performed an IP of THP-1 cells stably expressing V5-PQBP1, immunoblotted for endogenous cGAS, and found that PQBP1 physically associated with cGAS in the absence of immune stimulation ( Figure 6B ). Next, we expressed eYFPtagged PQBP1, V5-tagged cGAS, and FLAG-tagged STING in HEK293T, which lack both endogenous cGAS and STING, and immunoprecipitated PQBP1. As expected, cGAS co-immunoprecipitated with PQBP1; in contrast, when PQBP1 and STING were expressed together in the absence of cGAS, we observed no interaction between the two proteins ( Figure 6C ). However, when PQBP1, cGAS, and STING were expressed simultaneously, STING was able to associate with PQBP1, indicating that PQBP1 is able to form a complex with STING bridged by cGAS ( Figure 6C ). To determine the domain necessary for PQBP1-cGAS interaction, two disease-associated mutations were generated: a truncation mutation that shortens the protein at the C terminus without disrupting the WW domain (delC) and an amino-acid substitution that disrupts the WW domain (WW) (Lenski et al., 2004) (Figure 6D ). Immunoprecipitation experiments revealed that PQBP1 required an intact WW domain (WW), but not a complete C terminus (delC), for binding cGAS ( Figure 6D ). The PQBP1 WW domain has previously been shown to be required for interactions with other proteins (Ikeuchi et al., 2013; Salah et al., 2012) .
Next, we sought to determine which domain(s) of PQBP1 were necessary for DNA binding. To this end, we determined that recombinant PQBP1 (rPQBP1) specifically associated with HIV-1 DNA, as there was an enrichment of reverse-transcribed HIV-1 DNA, but not a HIV-1-encoding plasmid associated with rPQBP1 ( Figure 7A ). Then GST-tagged recombinant wild-type, C-terminal truncation (GST1-176), or WW domain mutant (GST-WW) proteins were generated, and each was incubated with non-chromatin DNA from cells infected with HIV/Vpx. A PQBP1 antibody was used to immunoprecipitate the recombinant proteins, and the amount of bound HIV-1 DNA was assessed using qPCR. Whereas wild-type and GST-WW bound HIV-1 DNA, GST1-176 associated with significantly less DNA ( Figure 7B ). Through fractionation, we determined that the WW domain and C-terminal truncation mutations did not affect the localization of PQBP1 ( Figure 7C ). We then confirmed these in vitro binding results using an in vivo nucleic acid binding assay. PQBP1-depleted cPQBP1 cells were stably reconstituted with wild-type, delC-PQBP1, or WW-PQBP1, and then the cells were infected with HIV/Vpx for 6 hr, formaldehyde cross-linked, and immunoprecipitated for PQBP1. Consistent with the in vitro studies, wild-type and WW-PQBP1 associated with HIV-1 DNA, but delC-PQBP1 did not ( Figure 7D ). Evaluation of ISG induction in these reconstituted cells following HIV/Vpx infection indicated that both cGAS and DNA binding domains were necessary for an immune response to viral challenge ( Figure 7E ).
Finally, we evaluated the innate response to HIV-1 infection in MDDCs derived from two Renpenning syndrome patients. The two male patients harbor a genetic mutation in the X-linked PQBP1 locus that results in a C-terminal truncation of amino acids 153-265 in the protein. MDDCs derived from the patients and healthy donors were challenged with HIV/Vpx for 8 hr, after which time ISG54 expression was measured ( Figure 7F ). Although paired healthy and Renpenning patient cells were infected to similar levels ( Figure S6A ), MDDCs from both Renpenning patients displayed severely impaired induction of ISG54 in comparison to infected healthy donors ( Figure 7F ).
DISCUSSION
In this study, we find that the host protein PQBP1 directly binds to an HIV-1 DNA PAMP generated after early infection and initiates innate signaling through cGAS. Our results also indicate that the HIV-1-encoded PAMP is likely based on a unique and discernable secondary structure, which is only generated during reverse transcription in the infected cell. Specifically, while PQBP1 binds reverse-transcribed HIV-1 DNA from infected cells, it is unable to associate with a HIV-1-encoding plasmid DNA, in vitro reverse-transcribed DNA (data not shown), or other DNA viruses ( Figure 7A) .
Interestingly, we observed that PQBP1 is not required for cGAS-dependent responses to all cytosolic DNAs but only those derived from retroviral infection. These results suggest that PQBP1 and cGAS form a pattern recognition receptor complex that specifically recognizes and responds to retroviral PAMP(s).
While cGAS may serve as a common catalytic module for a variety of cytosolic DNA ligands, its specific association with PQBP1 enables cGAS to sense HIV-1-encoded DNA ligands. Further studies are required to understand how PQBP1 modulates the activation of cGAS in response to HIV DNA.
The reported affinity of cGAS for DNA is poor (K D 20 mM), and recognition is promiscuous (Civril et al., 2013; Zhang et al., 2014) , inconsistent with its ability to specifically respond to small quantities of microbial PAMPs and/or self-DAMPs. It is currently unclear if cGAS requires co-sensors analogous to PQBP1 to detect non-retroviral cytoplasmic DNA, including HT-DNA. However, based on our results, we propose a model in which cGAS, by virtue of its association with specific co-receptors, such as PQBP1, increases its ability to recognize distinct molecular patterns encoded by pathogen-associated DNA. Similarly, LGP2 has been proposed to enhance the sensing ability of the cytoplasmic RNA sensor MDA5 (Bruns et al., 2014; Satoh et al., 2010) . Therefore, this model may apply to multiple innate immune sensors.
The experimental models in this report have relied on the introduction of Vpx, which alleviates the block of early reverse transcription at the minus strand strong stop in highly restrictive cells, such as DCs (Hrecka et al., 2011; Laguette et al., 2011) . Previous work has indicated that abortive HIV-1 infection results in the exposure of reverse-transcribed HIV-1 DNA intermediates to trigger cGAS-dependent IRF3 activation (Lahaye et al., 2013; Rasaiyaah et al., 2013) . We hypothesize that circumventing SAMHD1 restriction by Vpx increases the concentration of both productive and abortive (late) RT intermediate products during infection of myeloid cells, with the latter propagating a potent and detectable innate response in these cells. Although HIV-1 infection in the absence of Vpx does not induce a significant innate response in myeloid cells in vitro, immune induction during mucosal and acute infection has been observed in humans and non-human primate models (Abel et al., 2005; Katsikis et al., 2011) . Based on these observations, we propose that rare abortive infection events are sufficient to trigger an innate immune response in vivo, which is likely amplified during the course of natural infection. However, in the absence of Vpx, these occurrences cannot be robustly detected on a cell population level using current ex vivo cell culture model systems.
Finally, we find that PQBP1 mutations associated with Renpenning syndrome severely attenuate the innate immune response to HIV-1 infection in patient-derived myeloid cells. Remarkably, each disease-associated PQBP1 mutation resulted in a corresponding defect in the immune response to retroviruses. Although a potential link between the observed innate immune defect and the neurological impairments in Renpenning patients remains uncertain, these data suggest that there may be common features in the signaling architecture of the innate immune response and neural development.
In summary, our results present a molecular understanding of how HIV-1 and other retroviruses are uniquely and specifically recognized to trigger cell-autonomous antiviral responses. Further studies are warranted to better understand the specific molecular characteristics of the HIV-1 DNA intermediates that enable recognition by the PQBP1/cGAS axis and to determine how this recognition event contributes to an antiviral and (C) cPQBP1 THP-1 cells reconstituted with V5-tagged wild-type (WT), WW, or delC PQBP1 were fractionated as in Figure 6A , and the subcellular fractions were analyzed for the indicated proteins.
(D) cPQBP1 THP-1 cells, stably reconstituted with wild-type (WT), delC, or WW mutant PQBP1, were infected with HIV/Vpx for 6 hr and were subjected to formaldehyde cross-linking, followed by assaying for fold enrichment of HIV-1 DNA immunoprecipitated with the reconstituted PQBP1 protein over normal IgG control. Levels of PQBP1 protein immunoprecipitated are shown by western blot (bottom).
(legend continued on next page) adaptive immune response to HIV-1. The identification of PQBP1 as an immune regulator required for sensing of retroviral DNA provides an opportunity for the therapeutic development of pharmacological agonists that may improve the efficacies of HIV vaccines and prophylactics.
EXPERIMENTAL PROCEDURES
Cell Culture and Viral Infection This study was approved by the NIH through our Institute Biosafety Committee (IBC). Primary monocyte-derived dendritic cells (MDDCs) were subjected to siRNA transfection, and 2 days later they were infected with VSV-G pseudotyped HIV-1 virus harboring a firefly luciferase reporter and VLP-Vpx, as previously described (Manel et al., 2010) . Six to 16 hr post-infection, RNA was isolated from the cells and subjected to qRT-PCR analysis. For the viral replication assay, the infected MDDCs were harvested 48 to 72 hr post-infection and assayed for luciferase activity from the integrated provirus. For mutation analysis, peripheral blood mononuclear cells from both healthy donors and two male Renpenning patients (mutation c.459_462 delAGAG, resulting in type p.R153fs193X) were analyzed similar to above at the Paul-Ehrlich-Institut. Biological replicates within each experiment represent independent infection and/or treatments. Technical replicates represent qPCR replicates on each biological sample. Replicate experiments were performed with MDDCs derived from different donors. The human monocyte-like THP-1 cell line was differentiated by treating with 5 ng/ml PMA (phorbol myristate acetate) for 2 days, followed by siRNA transfection and viral infection as described for MDDCs.
Virus Production and Infection
Preparation of VSV-G-pseudotyped HIV-1 firefly luciferase (luc), FIV, and EIAV is described in the Supplemental Experimental Procedures. In general, 2.5 to 5 ng of p24 of HIV-1 virus or 10 4 -10 5 IU (infectious units) of FIV or EIAV were used per 25,000 PMA-THP. MHV-68 was a gift from Ren Sun at UCLA and used at MOI of five. VLP-Vpx was generated using the SIV3+ plasmid as previously described (Manel et al., 2010) . The Mount Sinai Department of Microbiology Virus Collection provided the Cantell strain of Sendai virus.
siRNAs and qRT-PCR siRNAs were introduced into either MDDCs or PMA-THP using Stemfect RNA transfection kits. Typically, 2.5-5 pmol of siRNAs and 0.14-0.18 ml of Stemfect were used for 2.5 3 104 cells. Forty-eight hours after siRNA transfection, cells were infected with indicated virus for 5 to 8 hr, followed by RNA isolation and qRT-PCR analysis. The siRNA that knocked down PQBP1 most consistently was used for all subsequent experiments. A list of the siRNAs and the qPCR primers that were used in these experiments is shown in Table S2 .
In Vivo Interaction Assay
Lysates prepared from MDDCs infected with HIV/Vpx for 6 hr (unless otherwise indicated), followed by formaldehyde cross-linking (see the Supplemental Experimental Procedures for detail), were subjected to immunoprecipitation with 3-5 mg of antibody. The co-precipitated nucleic acids were analyzed by either qRT-PCR or qPCR analysis. Unless indicated otherwise, the samples that were analyzed by qPCR only were treated with RNaseA/H digestion prior to proteinase K treatment. For the fractionation experiments, the cross-linked MDDCs were lysed in a Triton cell lysis buffer and the cleared supernatants (SNC) were separated from the pellets, which were resuspended in equal volumes of Triton cell lysis buffer supplemented with 0.2% SDS to generate a chromatin fraction (C). The primers used in this assay are shown in Table S2 .
PMA-differentiated THP-1 cells or MDDCs, uninfected or infected with HIV/ Vpx for 6-8 hr, were fractionated into cytosolic (S1), membrane and organelle (S2), and chromatin (P2) fractions (see the Supplemental Experimental Procedures for detail).
In Vitro Interaction Assay Recombinant GST-tagged wild-type and mutant PQBP1 proteins were incubated with extra-chromosomal DNA isolated from MDDCs or PMA-THP infected with HIV/Vpx using the Hirt extraction protocol (Arad, 1998) . Three hundred nanograms of GST or GST-PQBP1 protein was incubated with 100 ng of either extra-chromosomal DNA or a mixture of pNL43 HIV-1 provirus plasmid and pUC19 in a binding buffer, followed by immunoprecipitation with an antibody against either GST or PQBP1 (as indicated in each experiment). DNA that associated with the recombinant proteins was analyzed by qPCR using the HIV-1 3 0 LTR primer (Table S2 ).
Co-immunoprecipitation HEK293T lysates expressing GFP or GFP fused to wild-type, insertion C (delC), or A194G substitution (WW) PQBP1 and with V5-tagged cGAS were subjected to immunoprecipitation analysis.
Immunostimulatory Assay DNA that was isolated from the in vivo cross-linking interaction assay, either from the cellular fractions or from the immunoprecipitants, were treated as in in vivo interaction assay, above. DNA was electroporated into THP-1 using the Neon transfection system (Life Technologies). Six to 8 hr post-electroporation, RNA was isolated from the cells and subjected to qRT-PCR analysis.
In Vitro Assay for cGAMP Activity The cGAMP activity assay was performed as described previously, with some modifications ; see the Supplemental Experimental Procedures). 
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